Jones Brian W, Hinkle Patricia M
Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, New York 14642, USA.
J Biol Chem. 2005 Nov 18;280(46):38346-54. doi: 10.1074/jbc.M502918200. Epub 2005 Sep 23.
The G protein-coupled thyrotropin-releasing hormone (TRH) receptor is phosphorylated and binds to beta-arrestin after agonist exposure. To define the importance of receptor phosphorylation and beta-arrestin binding in desensitization, and to determine whether beta-arrestin binding and receptor endocytosis are required for receptor dephosphorylation, we expressed TRH receptors in fibroblasts from mice lacking beta-arrestin-1 and/or beta-arrestin-2. Apparent affinity for [(3)H]MeTRH was increased 8-fold in cells expressing beta-arrestins, including a beta-arrestin mutant that did not permit receptor internalization. TRH caused extensive receptor endocytosis in the presence of beta-arrestins, but receptors remained primarily on the plasma membrane without beta-arrestin. beta-Arrestins strongly inhibited inositol 1,4,5-trisphosphate production within 10 s. At 30 min, endogenous beta-arrestins reduced TRH-stimulated inositol phosphate production by 48% (beta-arrestin-1), 71% (beta-arrestin-2), and 84% (beta-arrestins-1 and -2). In contrast, receptor phosphorylation, detected by the mobility shift of deglycosylated receptor, was unaffected by beta-arrestins. Receptors were fully phosphorylated within 15 s of TRH addition. Receptor dephosphorylation was identical with or without beta-arrestins and almost complete 20 min after TRH withdrawal. Blocking endocytosis with hypertonic sucrose did not alter the rate of receptor phosphorylation or dephosphorylation. Expressing receptors in cells lacking Galpha(q) and Galpha(11) or inhibiting protein kinase C pharmacologically did not prevent receptor phosphorylation or dephosphorylation. Overexpression of dominant negative G protein-coupled receptor kinase-2 (GRK2), however, retarded receptor phosphorylation. Receptor activation caused translocation of endogenous GRK2 to the plasma membrane. The results show conclusively that receptor dephosphorylation can take place on the plasma membrane and that beta-arrestin binding is critical for desensitization and internalization.
G蛋白偶联的促甲状腺激素释放激素(TRH)受体在激动剂作用后会发生磷酸化并与β-抑制蛋白结合。为了确定受体磷酸化和β-抑制蛋白结合在脱敏过程中的重要性,并确定受体去磷酸化是否需要β-抑制蛋白结合和受体内吞作用,我们在缺乏β-抑制蛋白-1和/或β-抑制蛋白-2的小鼠成纤维细胞中表达TRH受体。在表达β-抑制蛋白的细胞中,对[³H]甲基TRH的表观亲和力增加了8倍,包括一种不允许受体内化的β-抑制蛋白突变体。在存在β-抑制蛋白的情况下,TRH会引起广泛的受体内吞作用,但在没有β-抑制蛋白时,受体主要保留在质膜上。β-抑制蛋白在10秒内强烈抑制肌醇1,4,5-三磷酸的产生。在30分钟时,内源性β-抑制蛋白使TRH刺激的肌醇磷酸产生减少了48%(β-抑制蛋白-1)、71%(β-抑制蛋白-2)和84%(β-抑制蛋白-1和-2)。相比之下,通过去糖基化受体的迁移率变化检测到的受体磷酸化不受β-抑制蛋白的影响。在添加TRH后15秒内,受体完全磷酸化。无论有无β-抑制蛋白,受体去磷酸化情况相同,在撤去TRH后20分钟几乎完全去磷酸化。用高渗蔗糖阻断内吞作用不会改变受体磷酸化或去磷酸化的速率。在缺乏Gαq和Gα11的细胞中表达受体或用药物抑制蛋白激酶C并不能阻止受体磷酸化或去磷酸化。然而,显性负性G蛋白偶联受体激酶-2(GRK2)的过表达会延迟受体磷酸化。受体激活导致内源性GRK2转位到质膜。结果确凿地表明,受体去磷酸化可以在质膜上发生,并且β-抑制蛋白结合对于脱敏和内吞作用至关重要。